SEC Form D filing

Spearhead Bio, Inc., 2026-06-23

An SEC Form D private-offering notice from Saint Louis, MO, a $1,750,000 filer-stated offering target in Biotech. Filed 2026-06-23. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Spearhead Bio, Inc. site↗ Verified via SEC Form D

Develops genome engineering technology (TAHITI, a CRISPR-compatible transposon-based gene insertion platform) to accelerate breeding of improved transgenic and non-transgenic crops.

Filed 2026-06-23Filed to raise $1,750,000First money in 2026-06-18Raised so far $1,200,000HQ (as filed) Saint Louis, MOSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified spearheadbio.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in Missouri →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source